In contrast to the well-defined functional effects of the AngII-AT1a receptor interaction, no study has employed both pharmacological and genetic approaches to defining effects of AT2 receptors on AngII-induced AAAs. This evidence concerns the gene AGTR2 and achalasia-alacrima syndrome.